Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. - Wikidata - wikimedia - TriplyDB

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q34629559

about

Recent advances in understanding idiopathic pulmonary fibrosis Lung transplantation in IIP: A review Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers Respiratory disease and respiratory physiology: putting lung function into perspective interstitial lung disease Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials Predicting pulmonary fibrosis disease course from past trends in pulmonary function.Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.Hsp90 regulation of fibroblast activation in pulmonary fibrosis.Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.Update in diffuse parenchymal lung disease 2011 The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.Pulmonary hypertension in patients with idiopathic pulmonary fibrosis - the predictive value of exercise capacity and gas exchange efficiency.Idiopathic pulmonary fibrosis: CT and risk of death.Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT).Clinical characteristics of idiopathic pulmonary fibrosis patients with gender, age, and physiology staging at Okinawa Chubu Hospital.Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.Clinical impact of high-attenuation and cystic areas on computed tomography in fibrotic idiopathic interstitial pneumonias.Models of disease behavior in idiopathic pulmonary fibrosis.Prognosis of nonspecific interstitial pneumonia correlates with perivascular CD4+ T lymphocyte infiltration of the lung.Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis.A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema.Patient-reported outcomes in idiopathic pulmonary fibrosis research Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry.Outcome Measures for Clinical Trials in Interstitial Lung Diseases.The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis.Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study.Epidemiology of idiopathic pulmonary fibrosis.Relationship between survival and age in patients with idiopathic pulmonary fibrosis.Recommendations for the management of idiopathic pulmonary fibrosis in South Africa: a position statement of the South African Thoracic Society Body mass index-percent forced vital capacity-respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients.The diagnosis and treatment of idiopathic pulmonary fibrosis The treatment of idiopathic pulmonary fibrosis.The bronchiectasis severity index. An international derivation and validation study.

P2860

Q26745905-8848B686-E11D-4F6F-A88F-307E1C9F78D3 Q26774870-1F7D4E55-0D65-41F0-85C0-0660575E96E9 Q26864836-BDAC0D87-8D85-4BA9-A1E1-BBDD16E5F89E Q27001599-BDCCEFE0-8E5F-492A-A646-F58A9B73005A Q27008053-D1019C20-77D4-466B-B8FD-41F24C47FEB4 Q30359367-722EEE06-697B-404B-BC6E-1E234544465F Q30407660-BD508520-F64D-4D8A-B0B0-C4CE9849759E Q30415751-61971905-D679-4EEF-8D97-E3EC7FEAB0A1 Q30838920-A733D690-57DA-49F1-928E-4E3CBAD655BE Q31057145-E2B11EF1-DE5E-46F7-9C07-C635711AE162 Q33738931-DC02E7F3-C299-49CF-B429-47E5F1C743F0 Q34410117-85D22D00-B122-44A1-8917-314F2BED68C6 Q34804620-F7E72F81-431C-4A07-839E-57F6A45B7E84 Q35100635-3D2D86E1-F4D9-4232-80CA-6C90F923BC22 Q35673925-CDF2D9F8-BC6E-46BF-AF42-FFAD4E99A95F Q35681077-F5EA8EA9-DF32-4949-9932-90314E57C230 Q35683018-35BB8856-6B85-4AB1-83E2-2E1321F07EBC Q35707229-9D5497F8-FBA9-46E8-8E6D-94F44E6B9D3E Q35786052-210B4B2B-20E5-4548-A656-76B88969D073 Q35819353-34453A51-80A8-4888-8900-1E91FF08C9CB Q35825613-F4311139-8866-4A04-A073-8469B0710F4A Q35981766-6A0BBA15-528E-4B34-9E8C-DC4A0CD90BD9 Q36182189-D0124E32-BEE4-4A50-880E-44B8F7D838E5 Q36395539-97B1CED3-8F9A-43A6-815A-68EB1E77E0CE Q36472166-FE6C4DE5-3B55-40F6-960F-063A2AFB69D7 Q36726418-6F25BA75-BE01-4CFA-B46C-16B2BD756776 Q36813946-B14DE02B-4F50-4C41-A3C8-59B6A46A9C69 Q36949126-32FDA39A-6BC5-462A-82F4-5C8FA71C55E4 Q36957621-FC8F5E62-DFF7-496E-83D2-D962D3A2417F Q37094687-F695C904-6C52-4785-9BB4-191BB71BA4B8 Q37230492-926C885F-2A7E-4EA2-BFA6-50320937EEEC Q37345980-78C3F26E-AE31-4E53-B498-6E0FAF4B1141 Q37349367-87080895-8A7C-43A4-BD9A-EBBA48BF3640 Q37359126-2E340B03-42E0-48E3-AFAE-DEDD5BB0980D Q37528351-A4F8F76C-129A-4CAC-8502-009AF6833FF0 Q37581185-978A6857-5168-48B4-A84B-71FBFBE6F4B2 Q37581188-5CB69DD4-A384-43A4-8F9E-6CF2043B1C83 Q37592055-92804A4B-47A4-45C1-A62B-83798D36F4BF Q37621515-3A29B421-6649-4605-A2A9-F6153C62A1F7 Q37688482-AB933FB5-2A9D-4901-A128-BF618D5BADC3

P2860

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q34629559

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@ast

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@en

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@nl

type

label

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@ast

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@en

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@nl

prefLabel

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@ast

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@en

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@nl

P1433

Q34629559-E70D7CF2-970D-4A3C-83EA-6E5196D4BAF7

P1476

Q34629559-44411AFE-657E-491E-8B8E-ABA39F6CED97

P2093

Q34629559-017091D7-5009-4942-A426-ED82DFD7881A

Q34629559-115067FE-FACB-4675-A6DA-38A443F6FF9E

Q34629559-61BB035E-3FF8-4D24-8872-4940B504DE56

Q34629559-6C4FB955-A4AF-49B3-8EAB-D1625B156EF3

Q34629559-7117A739-D702-42C3-8B0C-79E2CB213750

Q34629559-A23F7985-1BA4-40A7-9C69-25B2C7F038EE

Q34629559-ABA86AE4-7498-45D1-9DA2-681A5479326F

Q34629559-BF6D9807-164D-458D-B76C-281E02E54657

Q34629559-C754B103-222C-445A-B4C1-FE880A8F98A0

Q34629559-CF6F1029-CD85-4FB0-B9A9-AF62C774F808

P304

Q34629559-4BA6B9F1-AF11-488F-B109-5C2F897CDC2D

P31

Q34629559-21873E68-0E47-44DF-BE78-436BD8974B0B

P356

Q34629559-DE5A75C6-0F1F-4AF4-B169-89C1AA6942F9

P407

Q34629559-5A70895B-1384-4CA4-B23A-F2B283913BFB

P433

Q34629559-878EFB52-6658-4EF2-A3C3-B4B729981C6B

P478

Q34629559-D858F2A6-534D-4E28-870F-D3C7A5CA354F

P50

Q34629559-446AD920-AFAB-43DE-8725-95945BF5CCD7

Q34629559-8CE18FC5-0865-4458-8CC2-960BB834A6AC

P577

Q34629559-2FD06FE7-CA11-4298-8E4F-05C94C0BDA59

P698

Q34629559-45CEC48B-6E8A-48D5-A393-02F7DC623670

P921

Q34629559-12AB9432-1A30-465C-94D7-A4F321BCF550

Q34629559-8C7F9777-7E1C-4B3E-8CD7-EBF90009DAA5

P356

RCCM.201011-1790OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Ascertainment of individual ri ...... idiopathic pulmonary fibrosis.

@en

P2093

Alex Kartashov

http://www.w3.org/2001/XMLSchema#string

Carlo Albera

http://www.w3.org/2001/XMLSchema#string

Derek Weycker

http://www.w3.org/2001/XMLSchema#string

Dominique Valeyre

http://www.w3.org/2001/XMLSchema#string

Ganesh Raghu

http://www.w3.org/2001/XMLSchema#string

Javier Szwarcberg

http://www.w3.org/2001/XMLSchema#string

Lisa Lancaster

http://www.w3.org/2001/XMLSchema#string

Paul W Noble

http://www.w3.org/2001/XMLSchema#string

Roland M du Bois

http://www.w3.org/2001/XMLSchema#string

Steven A Sahn

http://www.w3.org/2001/XMLSchema#string

P304

459-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201011-1790OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

Michiel Thomeer

Ulrich Costabel

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21616999

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis